A therapeutic strategy targeting a specific genetic mutation that causes a common form of amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig's disease, as well a type of frontotemporal dementia (FTD) has been designed by an international team led by scientists from the Florida campuses of The Scripps Research Institute (TSRI) and the Mayo Clinic. The scientists developed small-molecule drug candidates and showed they interfere with the synthesis of ...Friday, 15 August 2014
Scientists Successfully Target Common Mutation in Lou Gehrig's Disease and Frontotemporal Dementia
A therapeutic strategy targeting a specific genetic mutation that causes a common form of amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig's disease, as well a type of frontotemporal dementia (FTD) has been designed by an international team led by scientists from the Florida campuses of The Scripps Research Institute (TSRI) and the Mayo Clinic. The scientists developed small-molecule drug candidates and showed they interfere with the synthesis of ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment